DeDora Capital’s Boston Scientific BSX Stock Holding History

DeDora Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-188	Closed	-$8K	–	142
2022 Q1	$8K	Buy	+188	New	+$8.15K	﹤0.01%	316

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DeDora Capital's BSX Position: Q2 2022 in Review

DeDora Capital sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 188 shares — an estimated $8K sold.

DeDora Capital first reported a position in BSX in Q1 2022 and held it in 1 quarter. The position peaked at $8K in Q1 2022. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

DeDora Capital reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 188 Boston Scientific shares in Q2 2022, an estimated $8K.
DeDora Capital first reported a position in Boston Scientific in Q1 2022 and held it in 1 quarter.
DeDora Capital's Boston Scientific position peaked at $8K in Q1 2022.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.